290 related articles for article (PubMed ID: 35544321)
1. Graft-Versus-Host-Disease and Health-Related Quality of Life in Young Long-term Survivors of Cancer and Allogeneic Hematopoietic Stem Cell Transplantation.
Diep PP; Rueegg CS; Burman MM; Brinch L; Bø K; Fosså K; Landrø L; Loge JH; Lund MB; Massey RJ; Myrdal OH; Pathak M; Rimstad L; Tanem KE; Tjønnfjord GE; Aaløkken TM; Ruud E
J Adolesc Young Adult Oncol; 2023 Feb; 12(1):66-75. PubMed ID: 35544321
[No Abstract] [Full Text] [Related]
2. Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiation.
Gruber I; Koelbl O; Herr W; Holler E; Edinger M; Wolff D
Radiat Oncol; 2022 Nov; 17(1):195. PubMed ID: 36447269
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenia among patients after allogeneic hematopoietic stem cell transplantation and the impact of chronic graft-versus-host disease.
Ljubas Kelecic D; Lelas A; Karas I; Desnica L; Vukic T; Sabol I; Vranesic Bender D; Serventi Seiwerth R; Peric Z; Durakovic N; Vitali Cepo D; Vrhovac R; Nemet D; Pavletic S; Pulanic D; Krznaric Z
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2967-2978. PubMed ID: 32507973
[TBL] [Abstract][Full Text] [Related]
4. Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.
Fraile P; Vazquez L; Caballero D; Garcia-Cosmes P; López L; San Miguel J; Tabernero JM
Eur J Haematol; 2013 Aug; 91(2):129-34. PubMed ID: 23710658
[TBL] [Abstract][Full Text] [Related]
5. Oral chronic GVHD after allogeneic stem cell transplantation without total body irradiation performed at a young age.
Tanem KE; Wilberg P; Diep PP; Ruud E; Skaare AB; Brinch L; Herlofson BB
Support Care Cancer; 2022 May; 30(5):4121-4128. PubMed ID: 35075489
[TBL] [Abstract][Full Text] [Related]
6. Determinants of cardiorespiratory fitness in very long-term survivors of allogeneic hematopoietic stem cell transplantation: a national cohort study.
Myrdal OH; Diep PP; Ruud E; Brinch L; Massey RJ; Edvardsen E; Kongerud J; Lund MB; Sikkeland LI
Support Care Cancer; 2021 Apr; 29(4):1959-1967. PubMed ID: 32827056
[TBL] [Abstract][Full Text] [Related]
7. Late-Onset, Noninfectious Pulmonary Complications following Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Cohort Study of Long-Term Survivors.
Myrdal OH; Aaløkken TM; Diep PP; Ruud E; Brinch L; Fosså K; Mangseth H; Kongerud J; Sikkeland LI; Lund MB
Respiration; 2022; 101(6):544-552. PubMed ID: 34937032
[TBL] [Abstract][Full Text] [Related]
8. Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia.
Schleicher O; Horndasch A; Krumbholz M; Sembill S; Bremensdorfer C; Grabow D; Erdmann F; Karow A; Metzler M; Suttorp M
Front Oncol; 2022; 12():963223. PubMed ID: 36276159
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Morbidity and Mortality in Children with Chronic Graft-versus-Host Disease Classified by National Institutes of Health Consensus Criteria after Allogeneic Hematopoietic Stem Cell Transplantation.
Inagaki J; Moritake H; Nishikawa T; Hyakuna N; Okada M; Suenobu S; Nagai K; Honda Y; Shimomura M; Fukano R; Noguchi M; Kurauchi K; Tanioka S; Okamura J
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1973-80. PubMed ID: 26234723
[TBL] [Abstract][Full Text] [Related]
10. Predictors of post traumatic growth in allogeneic hematopoietic stem cell transplantation survivors: a cross-sectional survey.
McErlean G; Tapp C; Brice L; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Ward C; Kerridge I
BMC Psychol; 2023 Aug; 11(1):235. PubMed ID: 37587508
[TBL] [Abstract][Full Text] [Related]
11. Anxiety, depression, and mental health-related quality of life in survivors of pediatric allogeneic hematopoietic stem cell transplantation: a systematic review.
Di Giuseppe G; Thacker N; Schechter T; Pole JD
Bone Marrow Transplant; 2020 Jul; 55(7):1240-1254. PubMed ID: 31980743
[TBL] [Abstract][Full Text] [Related]
12. Multiple Breath Washout Testing to Identify Pulmonary Chronic Graft Versus Host Disease in Children After Hematopoietic Stem Cell Transplantation.
Rayment JH; Sandoval RA; Roden JP; Schultz KR
Transplant Cell Ther; 2022 Jun; 28(6):328.e1-328.e7. PubMed ID: 35139399
[TBL] [Abstract][Full Text] [Related]
13. Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study.
Gifford G; Sim J; Horne A; Ma D
Intern Med J; 2014 Feb; 44(2):139-47. PubMed ID: 24320824
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells in pediatric bronchiolitis obliterans syndrome (BoS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Mohseni R; Mahdavi Sharif P; Behfar M; Modaresi MR; Shirzadi R; Mardani M; Jafari L; Jafari F; Nikfetrat Z; Hamidieh AA
Stem Cell Res Ther; 2023 Sep; 14(1):256. PubMed ID: 37726865
[TBL] [Abstract][Full Text] [Related]
15. Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease.
Fall-Dickson JM; Mitchell SA; Marden S; Ramsay ES; Guadagnini JP; Wu T; St John L; Pavletic SZ;
Biol Blood Marrow Transplant; 2010 Jul; 16(7):948-956. PubMed ID: 20139026
[TBL] [Abstract][Full Text] [Related]
16. Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational study.
Soejima T; Shiohara M; Ishida Y; Inoue M; Hayakawa A; Sato A; Kamibeppu K; Atsuta Y; Yamashita T
Int J Hematol; 2021 Apr; 113(4):566-575. PubMed ID: 33386599
[TBL] [Abstract][Full Text] [Related]
17. Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy.
Lee CJ; Wang T; Chen K; Arora M; Brazauskas R; Spellman SR; Kitko C; MacMillan ML; Pidala JA; Badawy SM; Bhatt N; Bhatt VR; DeFilipp Z; Diaz MA; Farhadfar N; Gadalla S; Hashmi S; Hematti P; Hossain NM; Inamoto Y; Lekakis LJ; Sharma A; Solomon S; Lee SJ; Couriel DR
Transplant Cell Ther; 2024 Jan; 30(1):97.e1-97.e14. PubMed ID: 37844687
[TBL] [Abstract][Full Text] [Related]
18. Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia.
Jang JE; Kim SJ; Cheong JW; Hyun SY; Kim YD; Kim YR; Kim JS; Min YH
Ann Hematol; 2015 Feb; 94(2):275-82. PubMed ID: 25135450
[TBL] [Abstract][Full Text] [Related]
19. T helper 17 and regulatory T-cell profile and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in pediatric patients with beta-thalassemia.
Bayegi SN; Hamidieh AA; Behfar M; Saghazadeh A; Bozorgmehr M; Karamlou Y; Shekarabi M; Tajik N; Delbandi AA; Zavareh FT; Delavari S; Rezaei N
Transpl Immunol; 2023 Apr; 77():101803. PubMed ID: 36842567
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients.
Chen CT; Liu CY; Yu YB; Liu CJ; Hsiao LT; Gau JP; Chiou TJ; Liu JH; Liu YC
PLoS One; 2017; 12(9):e0185210. PubMed ID: 28934311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
